Additive In Vivo Growth-Inhibitory Effects of Flutamide and Finasteride on Androgen-Sensitive Shionogi 115 Carcinoma

    January 1996 in “ Endocrine-related Cancer
    Chunhui Chen, Xin Li, S. K. Singh, A. Bélanger, Fernand Labrie
    Image of study
    TLDR Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.
    The study found that combining the antiandrogen flutamide with the 5α-reductase inhibitor finasteride can inhibit prostate weight and Shionogi tumor growth in mice in an additive manner. The combination of both compounds may prove beneficial in the treatment of diseases where optimal inhibition of DHT formation and action is desired. The maximal inhibitory effects are obtained with the triple combination of castration, a pure antiandrogen, and a 5α-reductase inhibitor.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 32 results
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  478 upvotes 3 weeks ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

      community Any balding females? I need advice with coping :(

       16 upvotes 9 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

      community What ever happened to pyrilutamide?

      in Technology  48 upvotes 2 years ago
      Pyrilutamide, a potentially effective hair loss treatment; other topical treatments like RU58841 and CB-03-01 that may have fewer side effects than Pyrilutamide; and the Phase 3 clinical trials of Pyrilutamide, which is likely to be approved by the FDA soon.

    Related Research

    1 / 1 results